Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol
Title:
Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol
Author:
Weng, Liming Gong, Yan Culver, Jeffrey Gardell, Stephen J. Petucci, Christopher Morse, Alison M. Frye, Reginald F. Turner, Stephen T. Chapman, Arlene Boerwinkle, Eric Gums, John Beitelshees, Amber L. Borum, Peggy R. Johnson, Julie A. Garrett, Timothy J. McIntyre, Lauren M. Cooper-DeHoff, Rhonda M.